Efficacy of enterosorption in treatment of Covid-19 in pregnant women

Cover Page

Cite item

Full Text

Abstract

Objective. To optimize the treatment of pregnant women with a moderate form of COVID-19 by including a sorbent in complex therapy.

Materials and methods. Pregnant women (n = 87) with a gestational term of 30 weeks or more were divided into 2 groups. Group 1 (n = 42) received standard treatment for COVID-19. Group 2 (n = 45) received an additional preparation of colloidal silicon dioxide. The following endotoxemia indicators were assessed: concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), medium mass molecules (MМM). The course of pregnancy and complications of childbirth were evaluated.

Results. At the peak stage of the disease, in patients of group 2 the level of МММ was 0,43 opt. units lower, CRP – 7.1 mg / l lower, IL-6 – 2.3 ng / ml lower than in women of group 1.

Anemia, fetal growth retardation, threatening preterm birth, fetoplacental insufficiency, polyhydramnios and oligohydramnios was diagnosed rarely in group 2; the average fetal weight was 256 g more, the average fetal height was 2.4 cm more than in group 1. In group 2, there were fewer children with moderate and severe asphyxia.

Conclusions. The addition of colloidal silicon dioxide to the standard treatment of pregnant women with a moderate form of COVID-19 helps to reduce the level of endogenous intoxication, which is manifested by positive dynamics.

About the authors

A. V. Romanovskaya

V.I. Razumovsky Saratov State Medical University

Author for correspondence.
Email: annavictorovna@mail.ru

MD, PhD, Professor, Department of Obstetrics and Gynecology, Pediatric Faculty

Russian Federation, Saratov

E. V. Mikhailova

V.I. Razumovsky Saratov State Medical University

Email: annavictorovna@mail.ru

MD, PhD, Head of the Department of Pediatric Infectious Diseases and Polyclinic Pediatrics named after N.R. Ivanov

Russian Federation, Saratov

N. E. Denisyuk

V.I. Razumovsky Saratov State Medical University

Email: annavictorovna@mail.ru

Assistant, Department of Obstetrics and Gynecology, Pediatric Faculty

Russian Federation, Saratov

D. A. Tyapkina

V.I. Razumovsky Saratov State Medical University

Email: annavictorovna@mail.ru

Student

Russian Federation, Saratov

References

  1. Adamyan L.V., Kony`sheva O.V., Lyashko E.S., Kaznacheeva T.V., Fattaxova D.N., Gorbacheva E.Yu., Vechorko V.I. Features of obstetric care in conditions of coronavirus infection. Diagnostika i lechenie novoj koronavirusnoj infekcii. Organizaciya raboty` v usloviyax mnogoprofil`nogo stacionara: Rukovodstvo dlya vrachej. Pod red. V.I. Vechorko. Moscow: Praktika 2020; 242–253. doi: 10.51833/9785898161804_242 (in Rus-sian).
  2. Organization of medical care for pregnant women, women in childbirth, puerperas and newborns with a new coronavirus infection COVID-19: methodological recommendations. Version 4 (07/05/2021), available at: https://clck.ru/32UBmC (in Russian).
  3. Podoprigora G.I., Kafarskaya L.I., Bajnov N.A., Shkoporov A.N. Bacterial translocation from the intestine: microbiological, immunological and pathophysiological aspects. Vestnik Rossijskoj akademii medicinskix nauk 2015; 70 (6): 640–650. doi: 10.15690/vramn564 (in Russian).
  4. Zhu H., Wang L., Fang C., Peng S., Zhang L., Chang G., Xia S., Zhou W. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020; 9 (1): 51–60. doi: 10.21037/tp.2020.02.06.
  5. Romanovskaya A.V., Malyugina T.N., Mixajlova E.V., Malinina N.V., Zheleznikov P.A., Chudakova T.K., Serdyukov A.Yu., Raskina E.E., Burova O.S., Denisyuk N.E. Features of the course of a new coronavirus infection and the effectiveness of the use of nasal interferon in pregnant women with COVID-19 and newborns with perinatal contact. Voprosy` ginekologii, akusherstva i perinatologii 2021.20 (6): 65–71. doi: 10.20953/1726-1678-2021-6-65-71 (in Russian).
  6. Mixajlova E.V., Burova O.S., Denisyuk N.E., Romanovskaya A.V. New coronavirus infection in newborns. Rossijskij vestnik perinatologii i pediatrii 2022; 67 (4): 242 (in Russian).
  7. Men`shikova S.V., Ketova G.G., Popilov M.A. Little-known properties of Polysorb MP (colloidal silicon dioxide). Glavny`j vrach Yuga Rossii 2018; 1 (59): 32–34 (in Russian).
  8. Yulish E.I., Krivushhev B.I. Enterosorption method in the treatment of intoxication syndrome. Zdorov`e rebenka 2011; 4 (31): 76–81 (in Russian).
  9. Polyanceva E.P., Yagovkina N.V. Enterosorption method in the treatment of preeclampsia. Vyatskij medicinskij vestnik 2009; 1: 48–49 (in Russian).
  10. Torchinov A., Kuzneczov V., Czaxilova S., Ostaeva L., Saraxova D., Kravczova M. The effectiveness of the inclusion of enterosorbents in the treatment of endogenous intoxication in preeclampsia. Vrach 2013; 7: 69–71 (in Russian).
  11. Shhekina M.I., Panchuk M.S. Aspects of the use of enterosorbents for intoxication of various origins in outpatient practice. Medicinskij sovet 2013; 3–1; 67–71 (in Russian).
  12. Vershinin A.S., By`chkovskix V.A., Smirnov D.M. The use of the enterosorbent Polysorb MP (colloidal silicon dioxide) in the complex therapy of various pathological conditions accompanied by endotoxicosis (literature review). Vestnik Yuzhno-Ural`skogo gosudarstvennogo universiteta. Seriya: Obrazovanie, zdravooxranenie, fizicheskaya kul`tura 2013; 13 (3): 125–129 (in Russian).
  13. Gabrie`lyan N.I., Lipatova V.I. Experience in using the indicator of average blood molecules for diagnosing nephrological diseases in children. Laboratornoe delo 1984; 3: 138–140 (in Russian).

Copyright (c) 2023 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies